Jury Hands J&J, Bayer Win In 3rd Xarelto Bellwether

Law360, New York (August 18, 2017, 9:52 PM EDT) -- A Mississippi federal jury on Friday sided with Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. in a bellwether case brought by a woman claiming the blood thinner Xarelto caused gastrointestinal bleeding that required her hospitalization, according to the plaintiff’s and defendants’ representatives.

The trial was the third win for Janssen and Bayer in a bellwether trial in Louisiana multidistrict litigation over claims they didn't warn about the possibility of dangerous internal bleeding associated with the blood thinner. (AP) The trial was the third win for Janssen and Bayer in a bellwether trial in Louisiana multidistrict litigation over...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!